Abpro Holdings (ABPO) Times Interest Earned (2022 - 2026)
Abpro Holdings' (ABPO) quarterly Times Interest Earned came in at -$12.96 in Q1 2026, down 222.86% YoY from $10.55 in Q1 2025, and up 65.16% on a QoQ basis from -$37.2 in Q4 2025.
Abpro Holdings (ABPO) Times Interest Earned (2022 - 2026) Analysis & Trends
Abpro Holdings (ABPO) has 5 years of Times Interest Earned data on file, last reported at -$12.96 in Q1 2026.
- Quarterly Times Interest Earned fell 222.86% year-over-year to -$12.96 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.58 (down 62.0% YoY) and the FY2025 annual result came in at -$0.25, up 15.87% from the prior year.
- Times Interest Earned climbed to -$12.96 in Q1 2026, from -$37.2 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $100.08 in Q4 2023 to a low of -$68.55 in Q1 2024.
- A 5-year average of -$7.54 and a median of -$10.73 in 2024 frame the typical range for Times Interest Earned.
- Annual changes were most pronounced in 2023 — Times Interest Earned soared 6706.38% — and 2024, when it tumbled 376.75%.
- Tracing ABPO's Times Interest Earned over 5 years: stood at -$1.51 in 2022, then jumped by 6706.38% to $100.08 in 2023, then slumped by 109.68% to -$9.69 in 2024, then tumbled by 283.91% to -$37.2 in 2025, then surged by 65.16% to -$12.96 in 2026.
- The last three Times Interest Earned figures came in at -$12.96 (Q1 2026), -$37.2 (Q4 2025), and -$6.24 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Abpro Holdings | 1.14 Mn | 1.14 Mn | - | -51.09 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.96 |
| Dec 31, 2025 | -37.20 |
| Sep 30, 2025 | -6.24 |
| Jun 30, 2025 | -12.99 |
| Mar 31, 2025 | -4.01 |
| Dec 31, 2024 | -9.69 |
| Sep 30, 2024 | -11.77 |
| Jun 30, 2024 | -23.17 |
| Mar 31, 2024 | -68.55 |
| Dec 31, 2023 | 100.08 |
| Sep 30, 2023 | -2.47 |
| Dec 31, 2022 | -1.51 |